San Francisco Bay Area HIV Clinical Trials Unit for Prevention and Treatment
Official title: San Francisco Bay Clinical Trials Unit (CTU)
Funded at Public Health Foundation Enterprises · NIH-11578568 · Data updated 2026-11-12
A local HIV clinical trials program led by top Bay Area researchers aims to speed up prevention and treatment studies through community-engaged research across ACTG, HPTN, and HVTN networks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Public Health Foundation Enterprises NIH-funded |
| Lab location | 1 site (City of Industry, United States) |
| Project start | March 2, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $105,420 |
| NIH project number | 3UM1AI069496-20S1 |
| Project ID | NIH-11578568 on NIH RePORTER |
Who could benefit from this research
✓Could help
HIV prevention and treatment candidates in the San Francisco Bay Area, including MSM and people who inject drugs, who may participate in clinical trials.
✕Less likely to help
Individuals not eligible for or not interested in participating in HIV clinical trials may not directly benefit.
What this research studies
This grant funds a Bay Area Clinical Trials Unit focused on advancing HIV prevention and treatment science with strong community involvement. It supports efficient trial implementation, rigorous adherence to study protocols, and training of future leaders in HIV prevention and care. The unit includes two established clinical research sites and a network of investigators who work closely with communities at risk, including men who have sex with men and people who inject drugs. By leveraging existing networks, the program aims to enroll diverse participants and accelerate high-quality clinical trials relevant to the local epidemic.
Why it matters
Potential benefit: If successful, patients could experience faster access to innovative HIV prevention and treatment options and improved quality of care.
How similar studies have gone: Previous ACTG/HPTN/HVTN collaborations in urban settings have shown strong enrollment and adherence, informing efficient trial conduct.
Where this research is happening
-
Public Health Foundation Enterprises
City of Industry, United States Active
Researchers
- Principal investigator: Buchbinder, Susan — Public Health Foundation Enterprises
- Study coordinator: Buchbinder, Susan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.